Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Caixeta

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Circulation. Cardiovascular Interventions|May 6, 2015
Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System TrialsPhilippe Généreux, David R Rutledge, Tullio Palmerini, et al.
Journal of the American College of Cardiology|August 29, 2009
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stentsAdriano Caixeta, Martin B Leon, Alexandra J Lansky, et al.
Plos One|October 27, 2025
Smaller infarct size with ticagrelor vs. clopidogrel in STEMI patients: Insights from cardiac magnetic resonanceFrancisco A Fonseca, Adriano Caixeta, Gilberto Szarf, et al.
Circulation|June 3, 2011
Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trialTullio Palmerini, Roxana Mehran, George Dangas, et al.
Clinical Interventions in Aging|June 18, 2020
The Impact of Advanced Age on Major Cardiovascular Events and Mortality in Patients with ST-Elevation Myocardial Infarction Undergoing a Pharmaco-Invasive StrategyIzo Helber, Claudia Maria Rodrigues Alves, Stela Maris Grespan, et al.
JACC. Cardiovascular Interventions|January 15, 2011
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trialsAdriano Caixeta, Alexandra J Lansky, Patrick W Serruys, et al.
Einstein (Sao Paulo, Brazil)|October 31, 2025
Platypnea-orthodeoxia syndrome: echocardiography-guided percutaneous treatmentJoão de Azevedo, Fernando Hideki Sakamoto, Sofia Alves Figueiredo Faustino, et al.
Journal of the American College of Cardiology|June 4, 2011
Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysisGeorge D Dangas, Roxana Mehran, Eugenia Nikolsky, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 14, 2011
Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trialPhilippe Généreux, Roxana Mehran, Tullio Palmerini, et al.
American Heart Journal|February 15, 2011
Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trialDiaa A Hakim, George D Dangas, Adriano Caixeta, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Circulation. Cardiovascular Interventions|May 6, 2015
Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System TrialsPhilippe Généreux, David R Rutledge, Tullio Palmerini, et al.
Journal of the American College of Cardiology|August 29, 2009
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stentsAdriano Caixeta, Martin B Leon, Alexandra J Lansky, et al.
Plos One|October 27, 2025
Smaller infarct size with ticagrelor vs. clopidogrel in STEMI patients: Insights from cardiac magnetic resonanceFrancisco A Fonseca, Adriano Caixeta, Gilberto Szarf, et al.
Circulation|June 3, 2011
Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trialTullio Palmerini, Roxana Mehran, George Dangas, et al.
Clinical Interventions in Aging|June 18, 2020
The Impact of Advanced Age on Major Cardiovascular Events and Mortality in Patients with ST-Elevation Myocardial Infarction Undergoing a Pharmaco-Invasive StrategyIzo Helber, Claudia Maria Rodrigues Alves, Stela Maris Grespan, et al.
JACC. Cardiovascular Interventions|January 15, 2011
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trialsAdriano Caixeta, Alexandra J Lansky, Patrick W Serruys, et al.
Einstein (Sao Paulo, Brazil)|October 31, 2025
Platypnea-orthodeoxia syndrome: echocardiography-guided percutaneous treatmentJoão de Azevedo, Fernando Hideki Sakamoto, Sofia Alves Figueiredo Faustino, et al.
Journal of the American College of Cardiology|June 4, 2011
Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysisGeorge D Dangas, Roxana Mehran, Eugenia Nikolsky, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 14, 2011
Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trialPhilippe Généreux, Roxana Mehran, Tullio Palmerini, et al.
American Heart Journal|February 15, 2011
Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trialDiaa A Hakim, George D Dangas, Adriano Caixeta, et al.
Pageof 12